During the past decade, Center for Cancer Prevention and Care at Scott and White Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Cancer Prevention and Care at Scott and White Clinic" #1 sponsor was "Children's Oncology Group" with 21 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Aronex Pharmaceuticals" with 1 trials sponsored, "Center for International Blood and Marrow Transplant Research" with 1 trials sponsored and "FeRx" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Cancer Prevention and Care at Scott and White Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "National Marrow Donor Program" with 1 trials as a collaborator, "SWOG Cancer Research Network" with 1 trials as a collaborator and "Texas A&M University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Center for Cancer Prevention and Care at Scott and White Clinic" are "Leukemia" (11 trials), "Sarcoma" (5 trials), "Brain Tumors" (3 trials), "Central Nervous System Tumors" (3 trials) and "Myelodysplastic Syndromes" (3 trials). Many other conditions were trialed in "Center for Cancer Prevention and Care at Scott and White Clinic" in a lesser frequency.

Most popular intervention types in "Center for Cancer Prevention and Care at Scott and White Clinic" are "Drug" (25 trials), "Biological" (11 trials), "Radiation" (10 trials), "Procedure" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (12 trials), "vincristine sulfate" (11 trials), "etoposide" (10 trials), "radiation therapy" (10 trials) and "filgrastim" (8 trials). Other intervention names were less common.

The vast majority of trials in "Center for Cancer Prevention and Care at Scott and White Clinic" are 30 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Cancer Prevention and Care at Scott and White Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Center for Cancer Prevention and Care at Scott and White Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Cancer Prevention and Care at Scott and White Clinic, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Center for Cancer Prevention and Care at Scott and White Clinic has several departments that took part in Clinical trials: "Scott and White Cancer Institute" - 12 trials, "Baylor Scott and White Research Institute - Hematology/Oncology" - 2 trials